Sector report: Information Technology
Month: July 2021
CVCs poised to benefit from positive momentum
July-August 2021 issue editorial by James Mawson, editor-in-chief, Global Corporate Venturing
Daily Deal Round Up: July 19, 2021
Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.
Crunchbase analysis reports 290bn in total global funding this year
Crunchbase (CB) analysis reported between almost 290bn in total global funding volume so far this year, almost double the whole of last year.
Aurora shines in $13bn reverse merger
Paccar, Uber and Volvo Group are taking part in a $1bn PIPE supporting the autonomous driving technology developer’s reverse merger with Reinvent Technology Partners.
Blend Labs lands on NYSE in $360m IPO
The Salesforce-backed banking software producer floated at the top of its range and saw its shares rise on their first day of trading.
Lenskart to leverage $220m in funding
Temasek and Falcon Edge Capital co-led a late-stage round for the SoftBank-backed eyewear retailer valuing it at $2.5bn.
Mei Wei makes off with over $155m
New Hope Group was among the participants in the dental clinic franchise owner’s series B round, which lifted its overall funding past $200m.
Genvid generates $113m series C round
Samsung, NTT Docomo and Huya helped the livestreaming technology provider close a round that took its overall funding to $166m.
TScan takes in $100m through IPO
The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.
OM1 turns to Kaiser Permanente in $85m round
Kaiser Permanente co-led the medical data software provider’s latest round, pushing its total funding past the $170m mark.
Alibaba embarks on $258m GBA Fund
Alibaba’s Hong Kong-based corporate venturing fund will be the cornerstone investor in a vehicle focusing on startups connected to the GBA ecosystem.
Ribon Therapeutics cribs $65m
Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.
YuLife livens up with $70m
Target Global led the RGA-backed gamified life insurance platform’s series B round, which valued it at almost $350m.